[go: up one dir, main page]

WO2000061624A8 - 48 proteines secretees humaines - Google Patents

48 proteines secretees humaines

Info

Publication number
WO2000061624A8
WO2000061624A8 PCT/US2000/008980 US0008980W WO0061624A8 WO 2000061624 A8 WO2000061624 A8 WO 2000061624A8 US 0008980 W US0008980 W US 0008980W WO 0061624 A8 WO0061624 A8 WO 0061624A8
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/008980
Other languages
English (en)
Other versions
WO2000061624A1 (fr
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU40721/00A priority Critical patent/AU4072100A/en
Priority to JP2000611565A priority patent/JP2003500017A/ja
Priority to CA002365522A priority patent/CA2365522A1/fr
Priority to EP00920139A priority patent/EP1171460A4/fr
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of WO2000061624A1 publication Critical patent/WO2000061624A1/fr
Publication of WO2000061624A8 publication Critical patent/WO2000061624A8/fr
Anticipated expiration legal-status Critical
Priority to US10/105,299 priority patent/US7368527B2/en
Priority to US10/670,186 priority patent/US20070031842A1/en
Priority to US10/670,185 priority patent/US20070015162A1/en
Priority to US10/868,184 priority patent/US20070048818A1/en
Priority to US10/994,608 priority patent/US20070048297A1/en
Priority to US11/781,665 priority patent/US20070298491A1/en
Priority to US12/753,401 priority patent/US8410248B2/en
Priority to US13/848,789 priority patent/US20130203164A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des nouvelles protéines sécrétées humaines et des acides nucléiques isolés contenant les régions codantes des gènes codant pour lesdites protéines. Elle porte également sur des vecteurs, sur des cellules hôtes, sur des anticorps et sur des méthodes de recombinaison pour la production de protéines sécrétées humaines. Elle se rapporte encore à des méthodes diagnostiques et thérapeutiques utiles pour le diagnostic et le traitement de maladies, de troubles et/ou d'états liés à ces nouvelles protéines sécrétées humaines.
PCT/US2000/008980 1999-03-12 2000-04-06 48 proteines secretees humaines Ceased WO2000061624A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU40721/00A AU4072100A (en) 1999-04-09 2000-04-06 48 human secreted proteins
JP2000611565A JP2003500017A (ja) 1999-04-09 2000-04-06 ４８個のヒト分泌タンパク質
CA002365522A CA2365522A1 (fr) 1999-04-09 2000-04-06 48 proteines secretees humaines
EP00920139A EP1171460A4 (fr) 1999-04-09 2000-04-06 48 proteines secretees humaines
US10/105,299 US7368527B2 (en) 1999-03-12 2002-03-26 HADDE71 polypeptides
US10/670,186 US20070031842A1 (en) 1999-03-12 2003-09-25 379 human secreted proteins
US10/670,185 US20070015162A1 (en) 1999-03-12 2003-09-25 99 human secreted proteins
US10/868,184 US20070048818A1 (en) 1999-03-12 2004-06-16 Human secreted proteins
US10/994,608 US20070048297A1 (en) 1999-03-12 2004-11-23 Human secreted proteins
US11/781,665 US20070298491A1 (en) 1999-03-12 2007-07-23 Human Secreted Proteins
US12/753,401 US8410248B2 (en) 1999-03-12 2010-04-02 HWBAO62 polypeptides
US13/848,789 US20130203164A1 (en) 1999-03-12 2013-03-22 Human Secreted Proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12870099P 1999-04-09 1999-04-09
US60/128,700 1999-04-09
US17693000P 2000-01-20 2000-01-20
US60/176,930 2000-01-20

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/008981 Continuation-In-Part WO2000061625A1 (fr) 1999-03-12 2000-04-06 48 proteines secretees humaines
PCT/US2000/009071 Continuation-In-Part WO2000061629A1 (fr) 1999-03-12 2000-04-06 49 proteines humaines secretees

Related Child Applications (4)

Application Number Title Priority Date Filing Date
PCT/US2000/008981 Continuation-In-Part WO2000061625A1 (fr) 1999-03-12 2000-04-06 48 proteines secretees humaines
PCT/US2000/009071 Continuation-In-Part WO2000061629A1 (fr) 1999-03-12 2000-04-06 49 proteines humaines secretees
US95008301A Continuation-In-Part 1999-03-12 2001-09-12
US95008201A Continuation-In-Part 1999-03-12 2001-09-12

Publications (2)

Publication Number Publication Date
WO2000061624A1 WO2000061624A1 (fr) 2000-10-19
WO2000061624A8 true WO2000061624A8 (fr) 2001-03-08

Family

ID=26826863

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/008980 Ceased WO2000061624A1 (fr) 1999-03-12 2000-04-06 48 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1171460A4 (fr)
JP (1) JP2003500017A (fr)
AU (1) AU4072100A (fr)
CA (1) CA2365522A1 (fr)
WO (1) WO2000061624A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002238483A1 (en) * 2001-01-03 2002-07-16 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
CA2445982A1 (fr) 2001-05-03 2002-11-14 Children's Medical Center Corporation Canal cationique specifique du sperme, et utilisations correspondantes
AU2002364939A1 (en) 2001-10-22 2003-07-09 Board Of Regents, The University Of Texas System Sperm-specific cation channel, catsper2, and uses therefor
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
WO2004015067A2 (fr) 2002-08-07 2004-02-19 Children's Medical Center Corporation Canal cationique specifique du sperme, catsper-3, et utilisations correspondantes
WO2004015066A2 (fr) 2002-08-07 2004-02-19 Children's Medical Center Corporation Canal cationique specifique au sperme, catsper-4, et utilisations
WO2013171595A1 (fr) * 2012-05-16 2013-11-21 Ramot At Tel-Aviv University Ltd. Nouveaux composés et procédés pour l'inhibition de la mort cellulaire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques

Also Published As

Publication number Publication date
WO2000061624A1 (fr) 2000-10-19
AU4072100A (en) 2000-11-14
CA2365522A1 (fr) 2000-10-19
EP1171460A1 (fr) 2002-01-16
JP2003500017A (ja) 2003-01-07
EP1171460A4 (fr) 2002-10-09

Similar Documents

Publication Publication Date Title
EP1053245A4 (fr) 45 proteines humaines secretees
WO1998039446A3 (fr) 70 proteines humaines secretees
WO1998039448A3 (fr) 186 nouvelles proteines secretees
WO1998040483A3 (fr) 28 proteines secretees par l'homme
WO1998031800A3 (fr) Proteines humaines
WO2001036432A3 (fr) 18 proteines secretees humaines
WO2001032910A3 (fr) 27 proteines humaines secretees
WO1998045712A3 (fr) 20 proteines humaines secretees
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO2001012776A3 (fr) 18 proteines secretees humaines
WO2001034768A3 (fr) 15 proteines secretees humaines
WO2000017222A8 (fr) 31 proteines humaines secretees
WO2000077026A8 (fr) 49 proteines secretees humaines
WO2000052136A3 (fr) Enzymes de glycosylation humaines
WO2000063230A3 (fr) 49 proteines secretees humaines
WO2001062891A3 (fr) 207 proteines humaines secretees
WO2000073323A3 (fr) Polynucléotides et polypeptides adam
EP1042342A4 (fr) 53 proteines secretees humaines
WO2001012775A8 (fr) 25 proteines secretees humaines
WO2000058339A3 (fr) 50 proteines humaines secretees
WO2000043495A3 (fr) Proteines humaines secretees (33)
WO2000061624A8 (fr) 48 proteines secretees humaines
WO2000061596A8 (fr) 50 proteines humaines secretees
WO2003052377A9 (fr) 41 proteines secretees humaines
WO2002099066A3 (fr) 20 proteines humaines secretees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase in:

Ref document number: 2365522

Country of ref document: CA

Ref country code: CA

Ref document number: 2365522

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2000 611565

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000920139

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000920139

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000920139

Country of ref document: EP